Skip to main content
. 2018 Apr 17;15(6):9025–9032. doi: 10.3892/ol.2018.8511

Figure 2.

Figure 2.

Knockdown of LSD1 inhibits cell-cycle progression via the G1 phase. (A) LSD1-KD cells were treated with 100 ng/ml Dox for 48 h. Flow cytometric analysis (left and middle panels) and quantitation (right panel) indicated that knockdown of LSD1 significantly induced cell cycle arrest in the G1 phase. (B) Reverse transcription-quantitative polymerase chain reaction analysis revealed a decrease in cyclin D1 and CDK2 and an increase in p21Cip1 mRNA expression levels. Data represented as the mean ± standard error of the mean (n=3). The data were analyzed by Student's t-test (*P<0.05). CDK2, cyclin-dependent kinase 2; Dox, doxycycline; LSD1, lysine-specific demethylase 1; LSD1-KD, Dox-mediated LSD1 knockdown of cells transduced with pLKO-LSD1-short hairpin RNA; p21Cip1, cyclin dependent kinase inhibitor 1.